These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 32453385)

  • 1. Time Trends in the Diagnosis of Colorectal Cancer With Obstruction, Perforation, and Emergency Admission After the Introduction of Population-Based Organized Screening.
    Decker KM; Lambert P; Nugent Z; Biswanger N; Samadder J; Singh H
    JAMA Netw Open; 2020 May; 3(5):e205741. PubMed ID: 32453385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for obstruction, perforation, or emergency admission at presentation in patients with colorectal cancer: a population-based study.
    Rabeneck L; Paszat LF; Li C
    Am J Gastroenterol; 2006 May; 101(5):1098-103. PubMed ID: 16573783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Rates of Colon Cancer Screening Use in Winnipeg, Canada: The Experience of a Universal Health-Care System with an Organized Colon Screening Program.
    Decker KM; Demers AA; Nugent Z; Biswanger N; Singh H
    Am J Gastroenterol; 2015 Dec; 110(12):1640-6. PubMed ID: 26169513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal trends in new diagnoses of colorectal cancer with obstruction, perforation, or emergency admission in Ontario: 1993-2001.
    Rabeneck L; Paszat LF; Rothwell DM; He J
    Am J Gastroenterol; 2005 Mar; 100(3):672-6. PubMed ID: 15743367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
    Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
    JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interval colorectal cancer rates after Hemoccult Sensa and survival by detection mode for individuals diagnosed with colorectal cancer in Winnipeg, Manitoba.
    Decker KM; Nugent Z; Lambert P; Biswanger N; Singh H
    PLoS One; 2018; 13(9):e0203321. PubMed ID: 30180176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of Emergency First Presentations of Colorectal Cancer in Under-50 and Over-50 Year-Old Patients.
    Singh P; Patel K; Arya P; Singh E; Mishra A
    J Invest Surg; 2020 Jul; 33(6):514-519. PubMed ID: 30644772
    [No Abstract]   [Full Text] [Related]  

  • 8. [Compliance rate of screening colonoscopy and its associated factors among high-risk populations of colorectal cancer in urban China].
    Chen HD; Li N; Ren JS; Shi JF; Zhang YM; Zou SM; Zheng ZX; Zhang K; Dai M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):231-237. PubMed ID: 29973000
    [No Abstract]   [Full Text] [Related]  

  • 9. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
    Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
    J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced risk of emergency admission for colorectal cancer associated with the introduction of bowel cancer screening across England: a retrospective national cohort study.
    Geraghty J; Shawihdi M; Devonport E; Sarkar S; Pearson MG; Bodger K
    Colorectal Dis; 2018 Feb; 20(2):94-104. PubMed ID: 28736972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing income-related inequities in colorectal cancer screening: lessons learned from a retrospective analysis of organised programme and non-programme screening delivery in Winnipeg, Manitoba.
    Decker KM; Demers AA; Nugent Z; Biswanger N; Singh H
    BMJ Open; 2016 Feb; 6(2):e009470. PubMed ID: 26908517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of screening on the survival of colorectal cancer in Shanghai, China: a population based study.
    Li X; Zhou Y; Luo Z; Gu Y; Chen Y; Yang C; Wang J; Xiao S; Sun Q; Qian M; Zhao G
    BMC Public Health; 2019 Jul; 19(1):1016. PubMed ID: 31357981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative Outcomes of Screen-Detected vs Non-Screen-Detected Colorectal Cancer in the Netherlands.
    de Neree Tot Babberich MPM; Vermeer NCA; Wouters MWJM; van Grevenstein WMU; Peeters KCMJ; Dekker E; Tanis PJ;
    JAMA Surg; 2018 Dec; 153(12):e183567. PubMed ID: 30285063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socioeconomic Inequalities in Colorectal Cancer Screening in Korea, 2005-2015: After the Introduction of the National Cancer Screening Program.
    Mai TTX; Lee YY; Suh M; Choi E; Lee EY; Ki M; Cho H; Park B; Jun JK; Kim Y; Oh JK; Choi KS
    Yonsei Med J; 2018 Nov; 59(9):1034-1040. PubMed ID: 30328317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Colorectal Cancer Is Associated With Lower Disease Stage: A Population-Based Study.
    Kubisch CH; Crispin A; Mansmann U; Göke B; Kolligs FT
    Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1612-1618.e3. PubMed ID: 27085763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
    Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
    Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in colorectal cancer screening use after introduction of alternative screening offer in Germany: Prospective cohort study.
    Guo F; Chen C; Schöttker B; Holleczek B; Hoffmeister M; Brenner H
    Int J Cancer; 2020 May; 146(9):2423-2432. PubMed ID: 31291471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.